Download presentation
Presentation is loading. Please wait.
Published byOddgeir Thomassen Modified over 5 years ago
1
Complete pathologic response after neoadjuvant treatment with vemurafenib for malignant melanoma
Orit Kaidar-Person, MD, Ayelet Eran, MD, Gil Bar-Sela, MD Journal of the American Academy of Dermatology Volume 70, Issue 2, Pages e39-e41 (February 2014) DOI: /j.jaad Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions
2
Fig 1 Melanoma before neoadjuvant vemurafenib treatment. Tru-Cut biopsy from the recurrent skin lesion was positive for melanoma and left an open wound at the site, which required prolonged hospitalization. Journal of the American Academy of Dermatology , e39-e41DOI: ( /j.jaad ) Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions
3
Fig 2 Site of prior melanoma, shown in Fig 1, after 8 weeks of treatment with vemurafenib. Journal of the American Academy of Dermatology , e39-e41DOI: ( /j.jaad ) Copyright © 2014 American Academy of Dermatology, Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.